Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

- PMLiVE

Q&A with Tim Cockroft

PME interviews the founding director of akt health communications

- PMLiVE

Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers

Will also advance proteomics research

Cultivating a learner-led culture: agile learning and the growth mindset

In this month’s Smart Thinking blog on PM.Live.com, Michelle Sweet, Learning and Development Consultant at Lucid Group, discusses the needs for a learner-led culture and a growth mindset in the...

Lucid Group Communications Limited

- PMLiVE

Akcea gets first OK for Waylivra in rare triglyceride disorder

EU becomes the first market for the new drug

- PMLiVE

AZ’s bet on Daiichi’s rival to Kadcyla pays off

Pivotal phase 2 data backs investment

Sanofi reception

Sanofi’s Dupixent gains asthma approval in Europe

Drug on track to meet blockbuster forecasts

- PMLiVE

Bicycles Therapeutics enters dementia discovery with venture capital fund

Ambitious UK biotech expands research scope

- PMLiVE

World Ovarian Cancer Day: Current treatments and future hopes for ovarian cancer

Ovarian cancer is the second most lethal gynaecological cancer worldwide. To raise awareness of this often fatal disease, our article looks at its symptoms, current treatments and future therapies.

Porterhouse Medical Group

Stream on

The Netflix model and why it (kind of) works in healthcare

- PMLiVE

Novartis builds case for SMA gene therapy as FDA verdict looms

One shot therapy provided rapid improvement in motor function

Deep Value

Value-based healthcare is difficult because it’s deep

- PMLiVE

Lundbeck snaps up Abide Therapeutics for $400m

Also acquires its lead drug for Tourette’s syndrome

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links